Measuring the efficacy of psychopharmacological treatment of psychomotoric restlessness in dementia: clinical evaluation of tiapride.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Pharmacopsychiatry

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1055/S-2007-979475PMID 9065963
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Zuclopenthixol, melperone and haloperidol/levomepromazine in the elderly. Meta-analysis of two double-blind trials at 15 nursing homes in Norway.

  1992cited by this paper
• Reliability and clinical concepts underlying global judgments in dementia: implications for clinical research.

  1992cited by this paper
• The Brief Psychiatric Rating Scale (BPRS) and the Nurses' Observation Scale for Inpatient Evaluation (NOSIE) in the evaluation of positive and negative symptoms.

  1990cited by this paper
• A Metaanalysis of Controlled Trials of Neuroleptic Treatment in Dementia

  1990cited by this paper
• ["Beginning and end of dose" dyskinesias caused by L-DOPA].

  1977cited by this paper
• THE NURSES' OBSERVATION SCALE FOR INPATIENT EVALUATION: A NEW SCALE FOR MEASURING IMPROVEMENT IN CHRONIC SCHIZOPHRENIA.

  1965cited by this paper

• Efficacy of tiapride in the treatment of psychiatric disorders: A systematic review

  2022cites this paper
• Large Sample Size Fallacy in Trials About Antipsychotics for Neuropsychiatric Symptoms in Dementia

  2020influential citation
• A systematic review of the clinical effectiveness and cost-effectiveness of sensory, psychological and behavioural interventions for managing agitation in older adults with dementia.

  2014cites this paper
• Long-Term Management of Dementia

  2011cites this paper
• Representation of people with intellectual disabilities in randomised controlled trials on antipsychotic treatment for behavioural problems.

  2011cites this paper
• Validation of the Algase Wandering Scale (Version 2) in a cross cultural sample.

  2004cites this paper
• Pharmacological Treatment of Dementia: Summary

  2004cites this paper
• Behandlungseffekte auf Verhaltensstörungen, psychotische und somatische Symptome bei Patienten mit Demenz

  2004cites this paper
• Special Section—Behavioral symptoms of dementia:their measurement and intervention. Validation of the Algase Wandering Scale (Version 2) in across cultural sample

  2004cites this paper
• Pharmacological Treatment of Psychosis and Agitation in Elderly Patients with Dementia

  2002cites this paper
• Pharmacotherapy of agitation and psychotic symptoms in Alzheimer’s disease

  2002cites this paper
• Clinical management of agitation in the elderly with tiapride

  2001cites this paper
• CME Practice parameter : Management of dementia ( an evidence-based review ) Report of the Quality Standards Subcommittee of the American Academy of Neurology

  2001cites this paper
• Practice parameter: Management of dementia (an evidence-based review)

  2001cites this paper
• Tiapride in gerontopsychiatry

  2001cites this paper
• The Benzamide Tiapride: Treatment of Extrapyramidal Motor and Other Clinical Syndromes

  2000cites this paper
• [Biological therapies of behavioral and psychological symptoms of dementia: update and prospects].

  2000cites this paper
• Double blind study of tiapride versus haloperidol and placebo in agitation and aggressiveness in elderly patients with cognitive impairment

  2000cites this paper
• Fatal intoxication with melperone.

  2000cites this paper
• Behavioural Problems Associated With Dementia

  1999cites this paper
• Alzheimer’s Disease: Behavioral Management

  1999cites this paper
• [Value of tiapride for agitation in the elderly. Review of published studies].

  1998cites this paper
• A New Oral Formulation of Tiapride (Drops)

  1998cites this paper
• Psychopharmacological Treatment of Dementia

  1998cites this paper